Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Goldbourt

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Archives of Internal Medicine|February 8, 1993
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 StudyU Goldbourt, S Behar, H Reicher-Reiss, et al.
The American Journal of Medicine|April 1, 1993
Infarct site-related mortality in patients with recurrent myocardial infarction. SPRINT Study GroupY Moshkovitz, S Sclarovsky, S Behar, et al.
International Journal of Cardiology|January 8, 1999
The outcome of patients with a first non-Q wave acute myocardial infarction presenting with ST segment depression, ST segment elevation, or no ST deviations on the admission electrocardiogramM Haim, M Benderley, H Hod, et al.
Annals of Internal Medicine|July 1, 1992
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study GroupM Eldar, Z Sievner, U Goldbourt, et al.
Journal of the National Cancer Institute|July 1, 1986
Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10,000 middle-aged and elderly menU Goldbourt, E Holtzman, S Yaari, et al.
Cardiology|October 12, 1999
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-upE Z Fisman, A Tenenbaum, M Benderly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study GroupM Benderly, E Graff, H Reicher-Reiss, et al.
International Journal of Cardiology|April 3, 1999
Are coronary patients at higher risk with digoxin therapy? An ongoing controversyH Reicher-Reiss, M Jonas, V Boyko, et al.
Stroke|October 1, 1993
Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study GroupD Tanne, U Goldbourt, M Zion, et al.
The American Journal of Medicine|December 1, 1992
Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study GroupS Behar, A Panosh, H Reicher-Reiss, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Archives of Internal Medicine|February 8, 1993
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 StudyU Goldbourt, S Behar, H Reicher-Reiss, et al.
The American Journal of Medicine|April 1, 1993
Infarct site-related mortality in patients with recurrent myocardial infarction. SPRINT Study GroupY Moshkovitz, S Sclarovsky, S Behar, et al.
International Journal of Cardiology|January 8, 1999
The outcome of patients with a first non-Q wave acute myocardial infarction presenting with ST segment depression, ST segment elevation, or no ST deviations on the admission electrocardiogramM Haim, M Benderley, H Hod, et al.
Annals of Internal Medicine|July 1, 1992
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study GroupM Eldar, Z Sievner, U Goldbourt, et al.
Journal of the National Cancer Institute|July 1, 1986
Elevated systolic blood pressure as a predictor of long-term cancer mortality: analysis by site and histologic subtype in 10,000 middle-aged and elderly menU Goldbourt, E Holtzman, S Yaari, et al.
Cardiology|October 12, 1999
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-upE Z Fisman, A Tenenbaum, M Benderly, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study GroupM Benderly, E Graff, H Reicher-Reiss, et al.
International Journal of Cardiology|April 3, 1999
Are coronary patients at higher risk with digoxin therapy? An ongoing controversyH Reicher-Reiss, M Jonas, V Boyko, et al.
Stroke|October 1, 1993
Frequency and prognosis of stroke/TIA among 4808 survivors of acute myocardial infarction. The SPRINT Study GroupD Tanne, U Goldbourt, M Zion, et al.
The American Journal of Medicine|December 1, 1992
Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study GroupS Behar, A Panosh, H Reicher-Reiss, et al.
Pageof 14